As wearable and software-enabled technologies increasingly estimate physiological parameters such as oxygen saturation, blood pressure, and heart rate variability, regulatory classification has become a critical design consideration. The FDA’s General Wellness: Policy for Low Risk Devices clarifies when products using non-invasive sensing—such as optical sensing—may be considered general wellness products rather than regulated medical devices.  For developers conducting a cl

In clinical research for medical devices and wearable technologies, data quality is everything . Regulatory clearance depends not just on whether a study was conducted, but on whether the data generated is regulator-ready, reproducible, and scientifically defensible . Yet not all Service Providers (formally known as Clinical Research Organizations (CROs)) bring the same level of expertise, infrastructure, or dedicated staff to ensure that outcome.  Sponsors sometimes face a d

For medical device and wearable technology developers, the success of a clinical research study often hinges on one factor: the quality...

When preparing for a regulatory-grade validation study, the temptation is often to move quickly into execution. However, a carefully...

When developing a new medical device or wearable technology, navigating the FDA regulatory pathway can be complex and resource-intensive....

PRL research staff performing synchronized data collection at multiple sites to ensure consistent, FDA-compliant results. Why Multi-Site...

Sponsors often choose CROs based on price or speed, but the wrong partner can cost far more. Delayed timelines. Poor data. FDA...